Month: July 2024

TORONTO, July 05, 2024 (GLOBE NEWSWIRE) — Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to announce a shift from resource confirmation to focus primarily on growth and resource expansion following the recent set of milestones achieved by the Company including the NI 43-101 compliant mineral resource estimate (“MRE”) for the Cebolleta Project in New Mexico (see press release dated June 24, 2024), 12 months ahead of schedule. The Cebolleta Project holds potential for significant resource expansion, including at the Willie P target, which was not included in the MRE, the underexplored extension of mineralization remaining open along trend, and several other untested areas. The Westwater Canyon Member, the principal host rock for several large historic uranium...

NEW YORK, July 05, 2024 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold” or the “Company”) today provided the following updates regarding its operations and financial performance: Bitcoin Mining Update Stronghold mined 61 Bitcoin in June 2024 and generated approximately $0.1mm in energy revenue, which represents the equivalent of approximately 2 additional Bitcoin based on the average price of Bitcoin during the month. This equates to approximately 63 of Bitcoin-equivalent production in June 2024. The Company generated an estimated $4.0 million of revenue during June, a decrease of 24% compared to May 2024. The primary driver of the revenue decline in June was an approximately 0.9 EH/s lower average daily hash rate that was the result of three temporary factors: 1) voluntary curtailment due to the...

TORONTO, Ontario, July 05, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that it has entered into a second amending agreement dated July 5, 2024 (the “Amending Agreement”), in respect of the previously announced amalgamation agreement dated March 17, 2024, as initially amended by an amending agreement on May 28, 2024 (collectively the “Amalgamation Agreement”) among Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) and Titan, to result in the merger of Conavi and Titan (the “Proposed Transaction”). In addition, Titan is seeking an additional extension with the Toronto Stock Exchange (“TSX”) to hold its Annual General and Special Meeting of Shareholders (the “AGM”) on or before September 30, 2024. An update regarding Titan’s AGM and any extension...

TORONTO, July 05, 2024 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (the “Company” or “Captor”) announced today that the common shares of the Company will be consolidated at a ratio of 15 pre-consolidation common shares for 1 new post-consolidated common shares. No fractional post-consolidation common shares will be issued and no cash will be paid in lieu of fractional post-consolidation common shares, such that any fractional interest in common shares resulting from the Consolidation will be rounded down to the nearest whole common share. The shareholders of the Company passed a special resolution authorizing the Consolidation at a meeting of the Company’s shareholders on June 7, 2024. It is expected that the Company’s common shares will commence trading on a consolidated basis on the...

On 07.05.2024 AS Baltplast (a company registered in Estonia under register code 10029370, the „Bidder“) published information via the information system of Nasdaq Tallinn Stock Exchange on its intention to make a voluntary take-over bid to all the shareholders of Aktsiaselts Silvano Fashion Group („SFG“) for acquiring all the shares of SFG, which are not owned by the Bidder (the „Bid“). Respective stock exchange news is available here – https://view.news.eu.nasdaq.com/view?id=b0e2ae1e2987071994fffc27c84825a17&lang=et&src=notices. To the knowledge of SFG, the Bidder’s intention has not changed but since the arranging financing for the Bid took more time than initially expected the proceedings of the approval of the Bid by the Financial Supervision Authority were terminated upon the application of the Bidder. The Bidder intends...

HONOLULU, Hawaii, July 05, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its second quarter 2024 financial results on Friday, July 26, 2024 before the market opens.   First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time). To access the call by phone, participants will need to click on the following registration link:   https://register.vevent.com/register/BIa54af76e9f084d46ad036d683c1f6cd6, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A live webcast of the conference call, including a slide presentation,...

BRISBANE, Calif., July 05, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of a non-qualified stock option to purchase 160,000 shares of Class A common stock to David Johnson, Vera’s new Chief Operating Officer, under Vera’s 2024 Inducement Plan. Vera also announced that on July 2, 2024, the Compensation Committee granted additional inducement awards consisting of a non-qualified stock option to purchase 139,100 shares of Class A common stock and restricted stock units (RSUs) for 61,925 shares of Class A common stock to ten new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with...

MONTREAL, July 05, 2024 (GLOBE NEWSWIRE) — SRQ Resources Inc. (TSX-V: SRQ) (“SRQ” or the “Company”) is pleased to announce that it has retained DS Market Solutions Inc. (“DS Market”) to provide equity trading advisory and liquidity provider services in accordance with TSXV policies and subject to the approval of the TSXV. DS Market will trade the securities of the Company on the TSXV for the purpose of maintaining an orderly market. In consideration of the services provided by DS Market, the Company will pay DS Market a monthly fee of $5,000 from the Company’s available cash for a minimum term of one month and renewable for successive one-month terms thereafter. Either Party may terminate the arrangement by providing written notice to that effect 30 days prior to the end of the then current term. The services provided by DS...

Recruitment in NATiV3 clinical trial continues in both cohorts with over 80% of the targeted number of patients enrolled in the main cohort and 100% in the exploratory cohort of NATiV3. Analysis of the baseline characteristics of all patients randomized in the main cohort of NATiV3 show a patient profile similar to patients randomized in the NATIVE Phase IIb clinical trial. A blinded analysis of all randomized patients suggests weight gain plateaus and stabilizes between week 24 and 36. First visit of the last patient of NATiV3 is anticipated to occur during the second half of 2024, and topline results are expected at the beginning of the second half of 2026. Patent portfolio strengthened with new patent secured protecting the compound until 2043. The Company is currently working on multiple fronts to secure financing to fund the continuity...